Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson’s Disease

Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson’s Disease

Intrastriatal embryonic ventral mesencephalon grafts have been shown to integrate, survive, and reinnervate the host striatum in clinical settings and in animal models of Parkinson’s disease. However, this ectopic location does not restore the physiological loops of the nigrostriatal pathway and pro...

Full description

Bibliographic Details
Main Authors:	Marine Droguerre, Sébastien Brot, Clément Vitrac, Marianne Benoit-Marand, Laure Belnoue, Maelig Patrigeon, Anaïs Lainé, Emile Béré, Mohamed Jaber, Afsaneh Gaillard
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Cells
Subjects:	Parkinson’s disease intranigral transplantation L-DOPA behavior electrophysiological assessment
Online Access:	https://www.mdpi.com/2073-4409/11/7/1191

Similar Items

Long-Term Evaluation of Intranigral Transplantation of Human iPSC-Derived Dopamine Neurons in a Parkinson’s Disease Mouse Model
by: Sébastien Brot, et al.
Published: (2022-05-01)

Absence of a synergic nigral proapoptotic effect triggered by REM sleep deprivation in the rotenone model of Parkinson´s disease
by: Luana C Kmita, et al.
Published: (2019-09-01)

Dopamine control of pyramidal neuron activity in the primary motor cortex via D2 receptors
by: Clément eVitrac, et al.
Published: (2014-02-01)

Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants
by: Afsaneh Gaillard, et al.
Published: (2009-09-01)

Acute and Chronic Dopaminergic Depletion Differently Affect Motor Thalamic Function
by: Giuseppe Di Giovanni, et al.
Published: (2020-04-01)

Olfactory impairment in the rotenone model of Parkinson's disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
by: Laís Soares Rodrigues, et al.
Published: (2014-12-01)

Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: A bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats
by: Kerstin Buck, et al.
Published: (2008-02-01)

Monoaminergic Modulation of Motor Cortex Function
by: Clément Vitrac, et al.
Published: (2017-10-01)

Interaction between the 5-HT system and the basal ganglia: Functional implication and therapeutic perspective in Parkinson’s disease
by: Cristina eMiguelez, et al.
Published: (2014-03-01)

Beneficial Effects of Hyaluronan-Based Hydrogel Implantation after Cortical Traumatic Injury
by: Anaïs Lainé, et al.
Published: (2022-11-01)

Formulation optimization of palm-based nanoemulsion containing levodopa, an anti-parkinson’s drug
by: Zainol, Syafinaz
Published: (2014)

Multiphoton FLIM Analyses of Native and UVA-Modified Synthetic Melanins
by: Ana-Maria Pena, et al.
Published: (2023-02-01)

Clinical and Genetic Heterogeneity in a Cohort of Chinese Children With Dopa-Responsive Dystonia
by: Yan Chen, et al.
Published: (2020-02-01)

Irreversible incorporation of L-dopa into the C-terminus of α-tubulin inhibits binding of molecular motor KIF5B to microtubules and alters mitochondrial traffic along the axon
by: Agustina Zorgniotti, et al.
Published: (2021-01-01)

Efecto de diversos tratamientos en la cocción del frijol Mucuna sobre el contenido de L-Dopa
by: Carmen Luz García Echeverría, et al.
Published: (2006-06-01)

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation.
by: Couch, Y, et al.
Published: (2011)

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
by: Couch Yvonne, et al.
Published: (2011-11-01)

Metabolic Pathway Reconstruction Indicates the Presence of Important Medicinal Compounds in <i>Coffea</i> Such as L-DOPA
by: Thales Henrique Cherubino Ribeiro, et al.
Published: (2023-08-01)

Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys
by: Marc Morissette, et al.
Published: (2022-02-01)

Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
by: Hiromi Sano, et al.
Published: (2023-06-01)

Efecto de diversos tratamientos en la cocción del frijol Mucuna sobre el contenido de L-Dopa
by: Carmen Luz García Echeverría, et al.

Neurobiology of DOPA as a neurotransmitter /
by: Misu, Yoshimi, 1934-, et al.
Published: (2006)

Involvement of the L-DOPA receptor GPR143 in acute and chronic actions of methylphenidate
by: Hiraku Uchimura, et al.
Published: (2023-07-01)

Characterization and genetic variability of wheat genotypes for polyphenol oxidase (PPO) activity
by: A. S. Shitre1, G. Vishwakarma1, V. Kumar1, Swati Bharad2, U. G. Kachole3, N. M. Magar3, P. Shinde3 and B. K. Das1,*
Published: (2022-03-01)

Dopa-Responsive Dystonia: A Male Patient Inherited a Novel Deletion from an Asymptomatic Mother
by: Wendi Wang, et al.
Published: (2020-05-01)

Antiparkinson Prodrugs
by: Laura Serafina Cerasa, et al.
Published: (2008-01-01)

Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

6R-L-erythro-5,6,7,8-Tetrahydrobiopterin and Dopamine Release
by: Miwa Soichi, et al.
Published: (1995-11-01)

Parkinson’s Disease-Associated Melanin Steal [Retraction]
by: Hinz M, et al.
Published: (2021-03-01)

l-3,4-Dihydroxyphenylalanine induces ptosis through a GPR143-independent mechanism in mice
by: Suguru Ueda, et al.
Published: (2016-09-01)

Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease
by: Hassan Dakik, et al.
Published: (2021-03-01)

Characterization and toxicity of zinc aluminium layered double hydroxide-levodopa nanocomposite
by: Kura, Aminu Umar
Published: (2014)

The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI
by: Giulia Santo, et al.
Published: (2022-03-01)

L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of <i>G<sub>i</sub>- Protein- Coupled Receptors</i>
by: Eileen Tremmel, et al.
Published: (2020-12-01)

The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia
by: Mitchell J. Bartlett, et al.
Published: (2020-12-01)

Relevance of Dynamic <sup>18</sup>F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes
by: Shamimeh Ahrari, et al.
Published: (2021-12-01)

Effects of Carbidopa Premedication on <sup>18</sup>F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis
by: Marie Bros, et al.
Published: (2021-10-01)

DDC-Promoter-Driven Chemogenetic Activation of SNpc Dopaminergic Neurons Alleviates Parkinsonian Motor Symptoms
by: Dong-Chan Seo, et al.
Published: (2023-01-01)

A promising material for bone repair: PMMA bone cement modified by dopamine-coated strontium-doped calcium polyphosphate particles
by: Xing Liu, et al.
Published: (2019-10-01)

Management of L-Dopa Overdose in the Competitive Inhibition State [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)